Office of the Director, National Institutes of Health; Notice of Closed Meeting, 34212 [2020-11911]
Download as PDF
<![CDATA[
34212
Federal Register / Vol. 85, No. 107 / Wednesday, June 3, 2020 / Notices
Section RAI.10 Organization
The Office of Global Health (RAI) is
headed by the Director, who reports
directly to the Administrator, HRSA.
The Office of Global Health includes the
following components:
(1) Office of the Director (RAI) and
(2) Division of Global Programs
(RAI1).
lotter on DSK9F5VC42PROD with NOTICES
Section RAI.20 Function
Delete the functional statement for the
Office of Global Health (RAI) in its
entirety and replace with the following:
Office of Global Health (RAI)
The Office of Global Health serves as
the principal advisor to the
Administrator on global health issues.
Specifically, the Office of Global Health
(1) provides leadership, coordination,
and advancement of global health
programs relating to sustainable health
systems for vulnerable and at-risk
populations; (2) provides leadership
within HRSA for the support of global
health and coordinates policy
development with the HHS Office of
Global Affairs, other departmental
agencies, bilateral/multilateral
organizations, and other international
organizations and partners; (3) monitors
HRSA’s border health activities and
investments, in partnership with
HRSA’s Office of Regional Operations,
to promote collaboration and improve
health care access to those living along
the U.S. borders, such as the U.S.Mexico border and the U.S. Affiliated
Pacific Islands; (4) provides
management and oversight of
international programs aimed at
improving quality and innovation in
human resources for health, health
professions recruitment, education,
retention, and applied research systems;
(5) supports and conducts programs
associated with the international
migration and recruitment of health
personnel, foreign, and immigrant
health workers; (6) provides support for
the agency’s international travel and the
Department of State’s International
Visitors Leadership Program; and (7)
provides national leadership, including
serving as the Deputy Principal
representative and providing support to
the HRSA Administrator, implements
training, and systems strengthening
functions of the Global HIV/AIDS
Program as part of the President’s
Emergency Plan for AIDS Relief
(PEPFAR).
Division of Global Programs (RAI1)
The Division of Global HIV/AIDS
Program provides national leadership,
implements training, and systems
strengthening functions of the Global
VerDate Sep<11>2014
18:35 Jun 02, 2020
Jkt 250001
HIV/AIDS Program as part of PEPFAR.
This includes strengthening health
systems for delivery of prevention, care
and treatment services for people with
HIV/AIDS in PEPFAR-funded countries
and providing management and
oversight of international programs
aimed at improving quality and
innovation in health professions
education and training. The Division
will translate lessons learned from both
the domestic and Global HIV/AIDS
Programs grant recipient community.
The Division of Global HIV/AIDS
Program provides leadership in
improving care, treatment and support
services for People with HIV/AIDS
outside of the United States and its
territories. Specifically, the Division: (1)
In coordination with the Department of
State’s Office of the Global AIDS
Coordinator, plans, develops,
implements, evaluates, and coordinates
the activities of the clinical assessment
system strengthening; (2) provides
guidance and expertise to funded
programs; (3) develops funding
opportunity announcements and
program guidance documents; (4)
conducts on-site program reviews and
reviews of pertinent and required
reports, and activities to assess
compliance with program policies and
country priorities; (5) in conjunction
with other division, Bureau, and agency
entities, assists in the planning and
implementation of priority HIV
activities such as workgroups, meetings,
and evaluation projects; (6) collaborates
with other federal agencies and incountry partners in the implementation
of the PEPFAR program, and; (7)
provides management and oversight of
international programs aimed at
improving quality and innovation in
health professions education, retention,
training, faculty development and
applied research systems.
Section RAI.30, Delegation of Authority
All delegations of authority and redelegations of authority made to
officials and employees of affected
organizational components will
continue in them or their successors
pending further redelegation, if allowed,
provided they are consistent with this
reorganization.
This reorganization is effective upon
date of signature.
Authority: 44 U.S.C. 3101.
Dated: April 2, 2020.
Alex M. Azar II,
Secretary.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Office of Research
Infrastructure Programs Special Emphasis
Panel; Member Conflict: Scientific and
Technical Review Board on Biomedical and
Behavioral Research Facilities (STOD).
Date: July 24, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7717, Bethesda, MD 20892, 301–435–
0229, kenneth.ryan@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: May 28, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–11911 Filed 6–2–20; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2020–11769 Filed 6–1–20; 4:15 pm]
BILLING CODE 4165–15–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 9990
E:\FR\FM\03JNN1.SGM
03JNN1
]]>Agencies
[Federal Register Volume 85, Number 107 (Wednesday, June 3, 2020)]
[Notices]
[Page 34212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11911]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Office of Research Infrastructure Programs
Special Emphasis Panel; Member Conflict: Scientific and Technical
Review Board on Biomedical and Behavioral Research Facilities
(STOD).
Date: July 24, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3218, MSC 7717, Bethesda, MD 20892, 301-435-
0229, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: May 28, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-11911 Filed 6-2-20; 8:45 am]
BILLING CODE 4140-01-P
